Yuliya Snyder
Neurology with Special Qualifications in Child Neurology · Rochester, NYNPI 1811155625
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.2% of the total across 328 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,628 and has fallen 89.3% since, to $282 in 2025.
Across 328 payments — averaging $23.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Livanova USA, Inc.$1K
- AbbVie$865
- Sunovion Pharmaceuticals Inc.$718
- Supernus Pharmaceuticals, Inc.$639
- Lilly USA, LLC$420
- plus $2K from 18 others
What the payments were for
- Travel & lodging$3124%
- Food & beverage$6,82790%
- Education$4316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 55 | $1,544 |
| Livanova USA, Inc. | 10 | $1,062 |
| AbbVie(2 entities) | 71 | $865 |
| Sunovion Pharmaceuticals Inc. | 32 | $718 |
| Supernus Pharmaceuticals, Inc. | 39 | $639 |
| Lilly USA, LLC | 21 | $420 |
| Amgen | 6 | $402 |
| Neurelis, Inc. | 11 | $397 |
| Jazz Pharmaceuticals Inc. | 4 | $255 |
| Greenwich Biosciences, Inc. | 11 | $254 |
| Pfizer | 23 | $253 |
| Biohaven Pharmaceutical Holding Company Ltd. | 24 | $172 |
| UCB, Inc. | 7 | $143 |
| Biohaven Pharmaceuticals, Inc. | 1 | $115 |
| Axsome Therapeutics, Inc. | 1 | $97 |
| Upsher-smith Laboratories LLC | 3 | $62 |
| Amneal Pharmaceuticals LLC | 2 | $43 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Zyla Life Sciences, Inc. | 1 | $24 |
| Grifols USA, LLC | 1 | $23 |
| Aprecia Pharmaceuticals, LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
| Biomarin Pharmaceutical Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$937
- AJOVY$371
- AIMOVIG$246
- VALTOCO$243
- Epidiolex$240
- Austedo XR$125
- APTIOM$122
- NURTEC ODT$115
- UBRELVY$109
How this compares
$7,570 in reported general payments places this provider in the 80th percentile of 161 neurology with special qualifications in child neurology providers in New York.
See all neurology with special qualifications in child neurology providers in New York →
Other neurology with special qualifications in child neurology in Rochester
- Jonathan MinkRochester$54K
- Erika AugustineRochester$16K
- Evelyn BermanRochester$2K
- Claudia ChiribogaNew York$220K
- Eric SegalN White Plains$133K
- Kaleb YohayNew York$125K
- Heather LauNew York$103K
- Louis ManganasEast Setauket$86K
- Darryl DevivoNew York$67K
- Mary Lynn ChuNew York$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.